PlainRecalls
FDA Devices Critical Class I Ongoing

Alaris PCA Module 8120

Reported: November 15, 2023 Initiated: September 15, 2023 #Z-0186-2024

Product Description

Alaris PCA Module 8120

Reason for Recall

Alaris PCA Module 8120, Patient Controlled Analgesia infusion pump: compatible syringes labeling contains syringes that have not been validated.

Details

Recalling Firm
CareFusion 303, Inc.
Units Affected
86,393 units
Distribution
Worldwide Distribution: US (nationwide): AK, AL, AR, AS, AZ, CA, CO, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MP, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY; OUS (foreign): Canada, Germany, Cuba, Italy, Japan, South Korea, Turkey, United Arab Emirates, Australia, Bahrain, Botswana, Kuwait, Mexico, Netherlands, Philippines, Pakistan, Qatar, South Africa, Singapore, Belgium, Israel, India, New Zealand, Malaysia, Taiwan, Switzerland
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
Alaris PCA Module 8120. Recalled by CareFusion 303, Inc.. Units affected: 86,393 units.
Why was this product recalled?
Alaris PCA Module 8120, Patient Controlled Analgesia infusion pump: compatible syringes labeling contains syringes that have not been validated.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 15, 2023. Severity: Critical. Recall number: Z-0186-2024.